Prevalence of a First-Degree Relative With Colorectal Cancer and Uptake of Screening Among Persons 40 to 54 Years Old.


Journal

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
ISSN: 1542-7714
Titre abrégé: Clin Gastroenterol Hepatol
Pays: United States
ID NLM: 101160775

Informations de publication

Date de publication:
10 2020
Historique:
received: 04 06 2019
revised: 14 11 2019
accepted: 22 11 2019
pubmed: 7 12 2019
medline: 19 8 2021
entrez: 7 12 2019
Statut: ppublish

Résumé

People with a first-degree relative with colorectal cancer (CRC) are recommended to start CRC screening at age 40. However, there is limited information on how many people in different age groups have a known family history of CRC and how many of them have had a colonoscopy. We set up a multicenter, cross-sectional, population-based study in Germany to determine what proportions of persons in age groups from 40 to 54 years old have a known family history of CRC. We invited 160,000 persons to participate in an online survey from 2015 through 2016. We investigated what proportions of persons in each age group reported a family history of CRC and what proportions of persons underwent a colonoscopy examination using descriptive statistics and multiple logistic regression models. Of 28,711 responders to the online questionnaire (8428 were age 40-44 years, 9879 were age 45-49 years, and 10,404 were age 50-54 years), 2705 stated that they had a first-degree relative with CRC (9.4%). The prevalence of a first-degree relative with CRC increased with age: 7.5%, 9.6%, and 10.9% for people 40 to 44 years old, 45 to 49 years old, and 50 to 54 years old, respectively. The prevalence of a first-degree relative who received a diagnosis of CRC at age 70 years or older increased steadily with each age group. Although a greater proportion of people with a family history of CRC had undergone a colonoscopy examination (54.5%) than people without a family history of CRC (25.7%; P < .0001), large proportions of people within this risk group were not in compliance with the guidelines (54.8%, 47.6%, and 38.6% for ages 40-44 y, 45-49 y, and 50-54 y, respectively). One in 10 persons in Germany age 40 to 54 years old has a first-degree relative with CRC. Guidelines recommend initiation of screening at ages 40 to 45 years for people with a family history, yet at this age many people do not have a family history of CRC yet, and almost half of persons 40 to 54 years old with a family history of CRC have not yet received a screening colonoscopy.

Sections du résumé

BACKGROUND & AIMS
People with a first-degree relative with colorectal cancer (CRC) are recommended to start CRC screening at age 40. However, there is limited information on how many people in different age groups have a known family history of CRC and how many of them have had a colonoscopy.
METHODS
We set up a multicenter, cross-sectional, population-based study in Germany to determine what proportions of persons in age groups from 40 to 54 years old have a known family history of CRC. We invited 160,000 persons to participate in an online survey from 2015 through 2016. We investigated what proportions of persons in each age group reported a family history of CRC and what proportions of persons underwent a colonoscopy examination using descriptive statistics and multiple logistic regression models.
RESULTS
Of 28,711 responders to the online questionnaire (8428 were age 40-44 years, 9879 were age 45-49 years, and 10,404 were age 50-54 years), 2705 stated that they had a first-degree relative with CRC (9.4%). The prevalence of a first-degree relative with CRC increased with age: 7.5%, 9.6%, and 10.9% for people 40 to 44 years old, 45 to 49 years old, and 50 to 54 years old, respectively. The prevalence of a first-degree relative who received a diagnosis of CRC at age 70 years or older increased steadily with each age group. Although a greater proportion of people with a family history of CRC had undergone a colonoscopy examination (54.5%) than people without a family history of CRC (25.7%; P < .0001), large proportions of people within this risk group were not in compliance with the guidelines (54.8%, 47.6%, and 38.6% for ages 40-44 y, 45-49 y, and 50-54 y, respectively).
CONCLUSIONS
One in 10 persons in Germany age 40 to 54 years old has a first-degree relative with CRC. Guidelines recommend initiation of screening at ages 40 to 45 years for people with a family history, yet at this age many people do not have a family history of CRC yet, and almost half of persons 40 to 54 years old with a family history of CRC have not yet received a screening colonoscopy.

Identifiants

pubmed: 31809916
pii: S1542-3565(19)31384-9
doi: 10.1016/j.cgh.2019.11.044
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2535-2543.e3

Informations de copyright

Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Auteurs

Korbinian Weigl (K)

Division of Clinical Epidemiology and Aging Research, Heidelberg, Germany; German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany.

Kaja Tikk (K)

Division of Clinical Epidemiology and Aging Research, Heidelberg, Germany; German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany.

Michael Hoffmeister (M)

Division of Clinical Epidemiology and Aging Research, Heidelberg, Germany. Electronic address: m.hoffmeister@dkfz-heidelberg.de.

Jochen Hampe (J)

Gastroenterology and Hepatology, Medical Klinic I, University Clinic Dresden, Dresden, Germany.

Svitlana Igel (S)

Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.

Frank Kolligs (F)

German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany; Department of Medicine II, University of Munich, Munich, Germany; Department of Medicine, Gastroenterology, Hepatology and Infectiology, Helios Clinic Berlin-Buch, Berlin, Germany.

Stefanie J Klug (SJ)

Cancer Epidemiology, University Cancer Center, Technical University, Dresden, Germany; Epidemiology, Department of Sport und Health Sciences, Technical University of Munich, Munich, Germany.

Ulrich Mansmann (U)

Institute for Medical Informatics, Biometry and Epidemiology, Ludwig-Maximilians-University Munich, Munich, Germany.

Oliver Müller (O)

Outpatient Gastroenterology Clinic "Am Pragsattel," Stuttgart, Germany.

Jutta M Nagel (JM)

Department of Medicine II, University of Munich, Munich, Germany.

Marcus Pichler (M)

Outpatient Gastroenterology Clinic "Am Pragsattel," Stuttgart, Germany.

Matthias Schwab (M)

Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; German Cancer Consortium, German Cancer Research Center (Partner Site), Tuebingen, Germany; Department of Clinical Pharmacology, University Hospital, Department of Biochemistry and Pharmacy, University of Tuebingen, Stuttgart, Germany.

Dirk Schweigler (D)

Cancer Epidemiology, University Cancer Center, Technical University, Dresden, Germany.

Anna-Magdalena Stephan (AM)

Gastroenterology and Hepatology, Medical Klinic I, University Clinic Dresden, Dresden, Germany.

Enrico N De Toni (EN)

German Cancer Consortium, German Cancer Research Center (Partner Site), Tuebingen, Germany.

Hermann Brenner (H)

Division of Clinical Epidemiology and Aging Research, Heidelberg, Germany; German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany; Division of Preventive Oncology, German Cancer Research Center, National Center of Tumor Diseases, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH